How to Understand Oocyte and Embryo Grading

Laboratory Director: Hung Kuei-Hsiang

Why Are Oocyte and Embryo Evaluations Performed?

During assisted reproductive treatments, the Jin Hou Sheng medical team evaluates oocytes and embryos according to established embryology standards, carefully assessing their morphology and developmental progress. These evaluations provide important references for treatment planning and embryo selection.

The purpose of these assessments is to enhance treatment safety and improve the likelihood of success, not to guarantee specific outcomes.

Oocyte and embryo grading results are only one of several clinical reference indicators and cannot independently predict pregnancy success. Actual outcomes are influenced by multiple factors, including age, overall health, uterine environment, and other individual conditions. Personalized consultation with a physician is therefore recommended for a comprehensive understanding of each case.

I. Oocyte Maturity

Oocytes undergo several stages of maturation either in vivo or in vitro. Assessing maturity is critical because only mature oocytes can be fertilized.

1. GV (Germinal Vesicle Stage)
An immature oocyte with a visible nucleus containing genetic material. Not suitable for fertilization.

2. MI (Metaphase I Stage)
Meiosis has begun but is incomplete. The nucleus has disappeared, chromosomes align at the center, but the first polar body has not been extruded. Usually unsuitable for fertilization.

3. MII (Metaphase II Stage)
A very brief yet critical stage late in Meiosis II. This is the appropriate stage for fertilization (ICSI or conventional IVF).

II. Fertilized Egg (Day 1) to Blastocyst (Day 5) Grading Standards

1. Day 1: Fertilization Assessment

· Normal Fertilization (2PN): Two pronuclei (derived from one sperm and one oocyte); suitable for culture.

· Abnormal Fertilization (0PN, 1PN, ≥3PN): Generally, not suitable for transfer.

2. Day 2–3: Cleavage-Stage Embryo Grading

Based on cell number, symmetry, and fragmentation rate:

· Good Quality:
Appropriate cell number (Day 2: 4 cells; Day 3: 8 cells), good symmetry, fragmentation<10%.

· Fair Quality:
Slight deviation in cell number, fragmentation 10–25%.

· Poor Quality:
Uneven cells, fragmentation >25%.

3. Day 4–5

Day 4 Morula Grading (M1–M5):

· M1–M2 (Good / Fair):
High compaction, solid structure.

· M3–M4 (Poor):
Lower compaction, possible vacuoles or slower development.

Day 5 Blastocyst Grading (e.g., 4AB)

A. Number (1–6): Blastocyst Expansion Stage

1. Early Blastocyst: Cavity < 1/2 volume

2. Blastocyst: Cavity ≈ 1/2 volume

3. Full Blastocyst: Cavity fills zona pellucida

4. Expanded Blastocyst: Enlarged cavity, thinning zona

5. Hatching Blastocyst: Emerging from zona pellucida

6. Fully Hatched Blastocyst: Completely free of zona pellucida

B. First Letter (A–C): Inner Cell Mass (ICM – Fetus)

· A: Numerous, tightly packed cells

· B: Moderate number, loosely arranged

· C: Few, sparse cells

C. Second Letter (A–C): Trophectoderm (TE – Placenta)

· A: Many cells, cohesive epithelial layer

· B: Fewer cells, loose structure

· C: Very few, irregular cells

4. Day 5–6: Blastocyst Evaluation

III. References

Evaluation standards follow internationally recognized guidelines (e.g., ASRM, ESHRE).

Embryo assessments at Jin Hou Sheng Medical Clinic adhere to international reproductive medicine standards and are performed by fully trained embryologists.

· Evaluations do not determine chromosomal normality

· Evaluations cannot independently predict pregnancy success

Every oocyte and embryo has its own developmental potential.

Important Notes

This information is for general educational purposes only. Treatment evaluation and recommendations should be provided by qualified medical professionals based on individual conditions.

Every treatment journey is a collaborative process between you and the Jin Hou Sheng Medical Team. We are committed to delivering professional expertise and attentive care at every step of the way.

Frequently Asked Questions (Q&A) | Oocyte & Embryo Evaluation

Q1: Does a good embryo grade guarantee a higher success rate?
A: No.
Grading is only one reference indicator. Outcomes depend on multiple factors such as age, uterine condition, and overall health.

Q2: If the grading is not ideal, does that mean there is no possibility of success?

A: Not at all.
Many embryos with less-than-ideal grades have resulted in successful pregnancies and healthy births.

Q3: Why are some embryos not selected for transfer?
A:
The medical team considers treatment plans, embryo development, and individual patient conditions to determine the most suitable option. Not selected does not mean “poor quality.”

Q4: Can I know my oocyte or embryo grades?
A:
Yes. Results will be explained by physicians or embryologists during consultations to ensure clarity and prevent misunderstandings.

Q5: Are the embryo grading charts available online consistent with the grading system used at JHS Center?

A:
Different centers may use different guidelines and culture systems. Direct comparison is not recommended.

Q6: Does evaluation harm oocytes or embryos?
A:
No. Evaluation is part of standard clinical procedures and is conducted under controlled laboratory conditions with safety as the top priority.

Q7: What if I have questions about my evaluation results?
A:
You are welcome to ask during consultations. Physicians and embryologists will provide clear, personalized explanations.

Important Reminder
This Q&A is intended for general educational purposes only. Treatment evaluation and recommendations must be provided by qualified medical professionals in accordance with individual clinical conditions.